Akili to Participate in the Cowen 43rd Annual Health Care Conference
Akili, Inc. (Nasdaq: AKLI), a pioneer in digital medicine, will participate in the Cowen 43rd Annual Health Care Conference in Boston on March 8. Highlights include a panel discussion with Scott Kollins, Chief Medical Officer, at 8 AM on prescription digital therapeutics and a 9:50 AM fireside chat featuring Co-Founder and CEO Eddie Martucci along with President Matt Franklin. The company will engage with investors throughout the day. Akili is noted for its innovative treatments targeting cognitive impairments through engaging video game experiences, supported by rigorous clinical research.
- None.
- None.
On
-
8am :Scott Kollins ,Akili Chief Medical Officer, will represent the company on a panel discussion about prescription digital therapeutics (PDTs) and how PDTs can aid in overall care and outcomes. -
9:50 am : Fireside Chat withEddie Martucci , Akili Co-Founder and Chief Executive Officer &Matt Franklin , President and Chief Operating Officer
Company leaders will also meet with investors throughout the day on
About
View source version on businesswire.com: https://www.businesswire.com/news/home/20230202005499/en/
Investor Contact:
Chief Financial Officer
sshanbhag@akiliinteractive.com
Media Contact:
SVP, Communications
jdicarlo@akiliinteractive.com
Source:
FAQ
When is Akili participating in the Cowen 43rd Annual Health Care Conference?
Who will represent Akili at the Cowen Health Care Conference?
What time will the panel discussion on prescription digital therapeutics occur?
What is the focus of Akili's presentation at the conference?